ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,767, issued on April 14, was assigned to ELI LILLY AND COMPANY (Indianapolis).
"Compounds and methods targeting epiregulin" was invented by Catherine Brautigam Beidler (Poway, Calif.), Jeffrey Streetman Boyles (Indianapolis), Daniel Scott Girard (San Diego), Shannon Marie Harlan (Carmel, Ind.) and Michael Parvin Johnson (Carmel, Ind.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to epiregulin antibodies, compositions comprising the same, and methods of making and/or using the antibodies and/or compositions thereof for chronic pain disorders such as chronic osteoarthritis pain, or chronic diabetic peripheral neuropathy...